Mood stabilizers are not a standard treatment for ADHD, and no mood stabilizer has FDA approval for treating it. Stimulant medications remain the first-line choice across all major clinical guidelines. That said, mood stabilizers do play a real role for certain people with ADHD, particularly when emotional volatility, aggression, or a coexisting mood disorder like bipolar disorder is part of the picture.
What Mood Stabilizers Can and Can’t Do for Core ADHD Symptoms
The core symptoms of ADHD are inattention, hyperactivity, and impulsivity. Stimulants like methylphenidate and amphetamine-based medications are effective at reducing all three, and every major guideline (including recent Australian and Canadian recommendations) positions them as the go-to pharmacological option. Non-stimulant alternatives like atomoxetine and guanfacine sit in the second tier.
Mood stabilizers don’t appear on those treatment ladders for ADHD itself. One small randomized trial found lithium was as effective as methylphenidate for hyperactivity, impulsivity, and learning problems in adults with ADHD, but the study was limited in size and hasn’t been replicated at scale. A study of valproate in 40 children with both bipolar disorder and ADHD found it effectively treated their manic symptoms but had essentially no effect on ADHD symptoms. The overall pattern in the research is clear: stimulants reliably improve ADHD symptoms whether or not a mood stabilizer is also on board, while mood stabilizers alone don’t consistently move the needle on attention or focus.
Where Mood Stabilizers Actually Help
The strongest case for mood stabilizers in someone with ADHD isn’t about the ADHD itself. It’s about what comes alongside it. Emotional dysregulation, explosive irritability, and impulsive aggression are common in ADHD but aren’t always well controlled by stimulants alone.
Lithium, for instance, has shown a substantial reduction in unprovoked aggressive outbursts in children whose impulsive aggression didn’t respond to other treatments. Lamotrigine has shown some promise in a different direction: a two-year study of children taking low-dose lamotrigine found significant improvement in ADHD inattention scores (dropping from an average of about 9 to about 6 on a standard subscale) along with modest gains in IQ measures. That study involved children with a movement disorder, not ADHD specifically, so the results need cautious interpretation, but they suggest lamotrigine may have cognitive benefits worth exploring.
These findings don’t make mood stabilizers an ADHD treatment. They suggest mood stabilizers can address specific symptoms that overlap with or accompany ADHD, especially when those symptoms haven’t responded to standard options.
When ADHD and Bipolar Disorder Overlap
The most common clinical scenario where someone with ADHD ends up on a mood stabilizer is when they also have bipolar disorder. This overlap is surprisingly frequent, and it creates a genuine treatment dilemma: stimulants that help ADHD can potentially trigger manic episodes in people with bipolar disorder.
Canadian treatment guidelines are explicit on this point. For people with bipolar I disorder and ADHD, mood-stabilizing medications should be started first, before any ADHD medication is introduced. The goal is to get mood symptoms under control and reduce the risk that a stimulant will destabilize things. Standard options for the mood component include lithium, valproate, and certain antipsychotics. Once mood is stable, ADHD treatment (typically a stimulant) can be layered on carefully.
The picture is a bit different for bipolar II, where the risk of stimulant-triggered mania is less clear. Some people with bipolar II and ADHD may still need a mood stabilizer, but the sequencing is more flexible. In either case, the mood stabilizer is there to protect against mood episodes, not to treat ADHD directly. A study tracking youth with bipolar disorder and ADHD over 18 months found that lithium and valproate were equally effective at preventing mood relapses regardless of whether ADHD was present, but the ADHD symptoms still needed their own treatment.
Side Effects That Work Against ADHD Goals
One practical reason mood stabilizers aren’t used for ADHD on their own is that their side effect profiles can actually worsen the daily challenges ADHD creates. Weight gain is the most common concern. Around 20% of people on lithium gain more than 10 kilograms (about 22 pounds), and patients consistently rate it as their most distressing side effect. Lithium-related weight gain appears linked to increased thirst leading to consumption of high-calorie drinks, along with sodium and water retention.
Valproate carries a similar weight gain risk through a different mechanism. It appears to lower blood sugar, which can increase appetite and promote fat storage. Carbamazepine causes weight gain primarily through water retention. The one exception in this class is topiramate, which is actually associated with weight loss, though it’s not commonly used for ADHD.
Sedation and cognitive dulling are also concerns with several mood stabilizers. For someone already struggling with focus and mental sharpness, adding a medication that causes drowsiness or slowed thinking can feel counterproductive, even if it’s helping with mood or aggression.
The Monitoring Burden
Mood stabilizers require significantly more medical monitoring than typical ADHD medications. Before starting lithium, you’ll need blood work covering kidney function, thyroid levels, electrolytes, and a complete blood count. Once you’re on a stable dose, those labs repeat every three to six months indefinitely, because lithium can affect kidney and thyroid function over time. Your lithium blood level also needs checking after every dose change, since the gap between a therapeutic dose and a toxic one is narrow. Staying well-hydrated becomes important, especially during illness, exercise, or hot weather, because dehydration can push lithium levels into a dangerous range.
Valproate has its own monitoring requirements: liver function tests and blood counts before starting and every three to six months after. It carries a rare but serious risk of elevated ammonia levels in the blood, which can cause confusion, lethargy, or vomiting and requires immediate attention. Both lithium and valproate also pose significant risks during pregnancy, so regular pregnancy testing is part of the monitoring protocol for women of childbearing age.
This level of ongoing surveillance is manageable, but it’s a meaningful commitment compared to stimulant medications, which typically require periodic blood pressure checks and weight monitoring but no routine blood draws.
Who Might Benefit From This Combination
The people most likely to benefit from a mood stabilizer as part of their ADHD management fall into a few groups: those with a confirmed bipolar disorder diagnosis who need mood protection before starting stimulants, those with severe impulsive aggression that hasn’t responded to standard ADHD treatments, and those with significant emotional dysregulation that persists despite optimized stimulant therapy. In all these cases, the mood stabilizer is addressing something adjacent to ADHD rather than replacing ADHD-specific treatment.
If you’re currently on a stimulant and still struggling with emotional reactivity, irritability, or mood swings, it’s worth exploring whether those symptoms reflect undertreated ADHD, a coexisting mood condition, or something else entirely. The treatment path looks very different depending on the answer, and a mood stabilizer is only one of several options your provider might consider.